Model
Edge
Revance Therapeutics Inc.
0001532023
Filing type
4
Filing date
Feb 5, 2025
Updated
Feb 6, 2025 ยท 6:06 PM
Copy reference
Filing
4
Statement of Changes in Beneficial Ownership